On September 20th, BIOS’ “Hemoglobin oxygen carrier drugs and medical Devices” project was launched in Jintan Economic Development Zone, Changzhou City, Jiangsu Province. At the meeting, Chen Jinhu, Secretary of Changzhou Municipal Party Committee, met with Mr. Zheng Zhiheng, Chairman of Bios (Changzhou) Biotechnology Co., LTD.

Chen Jinhu, on behalf of Changzhou Municipal Party Committee and Municipal Government of Jiangsu Province, welcomed Mr. Zheng Zhiheng’s arrival and briefly introduced the economic and social development of Changzhou.​ He said that Changzhou is deeply learning the spirit of the Third Plenary session of the 20th Central Committee of the Communist Party of China and the spirit of the important instructions of Xi Jinping the General Secretary’s important speech on Jiangsu work, developing new quality productivity according to local conditions, and creating a first-class innovation highland of synthetic biology industry in the Yangtze River Delta. Bilateral cooperation has broad prospects and huge potential. It is hoped that enterprises will give full play to their own advantages and carry out in-depth cooperation with Changzhou in innovative research and development, clinical research, manufacturing and other aspects. Changzhou will continue to optimize the business environment, always be a good “shopkeeper” and “emergency doctor”, do a good job in service guarantee for project construction and enterprise development, and go all out to promote the early production of projects and early results.

Mr. Zheng Zhiheng, chairman of the company, said that Changzhou has a strong momentum of development, obvious geographical advantages, especially complete industrial supporting capabilities, and complete elements for the development of biomedical industry. The company is full of confidence in further expanding investment and developing cutting-edge biotechnology in Changzhou, and will actively seek more development convergence points in the future, deepen cooperation areas, and continue to expand cooperation space, so as to contribute to the high-quality development of Changzhou.

Bios Biotechnology Co., LTD., headquartered in Hong Kong, China, is an enterprise focusing on the research and development and industrial production of biomedicine and medical device products based on hemoglobin oxygen carriers. It has all the registered and registered drug licenses, intellectual property rights and proprietary technologies in the field of hemoglobin in the world, and is the global leader in the field of human and veterinary hemoglobin. The “Hemoglobin oxygen carrier Drug and medical Device Project” invested by the company in Jintan Economic Development Zone is mainly engaged in the research and development and manufacturing of human drugs, veterinary drugs and medical devices, providing solutions for tissue hypoxia caused by various diseases, and developing a number of products with hemoglobin as the central raw material, which can be widely used in medical treatment, beauty, blood loss and ischemia and other fields.